Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

3 AC&R Study Summaries: Maternal Health & SLE, Pregnancy Outcomes & Coordinated Ophthalmic & Rheumatologic Care

Arthritis Care & Research  |  Issue: February 2025  |  February 7, 2025

Maternal Health Insights in Patients with SLE

The impact of pregnancy readiness on lupus activity, maternal mental health & pregnancy outcomes

By Ceshae Harding, MD, & Megan Clowse, MD, MPH

Why was this study done? Patients with systemic lupus erythematosus (SLE) who are pregnant have increased risks of risks maternal and fetal mortality, preeclampsia and cesarean sections than do members of the general population. Helping women with SLE time their pregnancy to coincide with minimal lupus activity, use of pregnancy-compatible medications and when they desire conception may improve health and well-being for both the mother and infant. In this study among individuals with SLE who became pregnant, we explored the impact of medical readiness for pregnancy and personal readiness for pregnancy on the following: provider-reported disease activity, patient-perceived disease activity, mood symptoms, pregnancy-related health behaviors and pregnancy outcomes.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

What were the study methods? All study participants were enrolled in a prospective registry, met Systemic Lupus Collaborating Clinics (SLICC) criteria for SLE and had at least one pregnancy. Being medically ready for pregnancy was defined as: <1 g of proteinuria, no rheumatic teratogens at conception and continuing pregnancy-compatible SLE medications after conception. Being personally ready for pregnancy was defined as a planned pregnancy based on a London Measure of Unplanned Pregnancy ≥10. Multivariable logistic regression models estimated the association of pregnancy readiness with each outcome of interest.

What were the key findings? In patients with SLE, not being medically ready for pregnancy was associated with significantly higher provider-reported disease activity; however, these patients did not perceive themselves as having higher disease activity. Not being personally ready for pregnancy was associated with significantly higher patient-perceived disease activity and higher maternal symptoms of depression. Being both medically and personally ready for pregnancy was associated with lower rates of preeclampsia and improved gestational length.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

What were the main conclusions? For maternal mental health and quality of life among individuals with SLE, greater focus is needed on decreasing the incidence of unplanned pregnancy. To improve pregnancy outcomes, greater focus is needed on improving medical optimization prior to conception in this higher risk population.

What are the implications for patients & clinicians? Reproductive-aged individuals with chronic disease are a unique population in whom disease management should always account for reproductive potential and personal goals.

This study speaks to the critical need for provider-initiated discussions around pregnancy planning, which allows individuals with SLE to make informed decisions with regard to family planning. To improve maternal health in patients with SLE, we must work toward increasing the proportion of pregnancies that are planned and medically optimized.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsResearch ReviewsResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RopthalmologistpregnancyReading RheumUveitis

Related Articles

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy

    November 16, 2016

    The decision to continue or discontinue immunomodulatory medications during pregnancy is a difficult one for both patients and physicians. On the one hand, when left untreated, rheumatic conditions can cause harm to an unborn child, as well as to the pregnant mother. On the other hand, medications can be harmful to a developing fetus. In…

    The Chimeric Self

    February 1, 2007

    Michrochimerism research offers insights into several autoimmune conditions

    Treat to Target: Rheumatoid Arthritis in Pregnant Patients

    October 1, 2012

    A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences